IHRMF

PINK ISHARES MSCI JPN ORD

Oct 1, 2026 · 7:35 PM ET LAST TRADE Market Closed

$25.24 ↓ -0.38 (-1.48%) Trading Down from the previous close of $25.62, $0.31 below the day’s high of $25.56

YTD change: +2.99%
vs 20-day SMA: +1.35%
vs 200-day SMA: N/A

Price ranges

Previous day

$25.62 $25.78

open $25.78 close $25.62

-$0.15 (-0.60%)

Today

$25.24 $25.56

open $25.56 now $25.24

-$0.31 (-1.23%)

Past week

$25.07 $25.78

from $25.11 now $25.24

+$0.14 (+0.54%)

Past month

$23.45 $25.78

from $24.74 now $25.24

+$0.50 (+2.03%)

This year

$21.19 $25.78

from $24.51 now $25.24

+$0.73 (+2.99%)

Price & Performance

+3.11 (+13.80%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral

The stock is 2.1% away from all-time highs of $25.78
IHRMF is up 3% since the beginning of the year
IHRMF is up 3% over the past 12 months
IHRMF is up 2% over the past 1 month

IHRMF reads neutral: the 12-month move is +22.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A

EPS N/A

Earnings momentum N/A Quarterly EPS growth

Quarterly change N/A

Valuation

P/E ratio N/A

Balance sheet & scale

IncomeN/A

RevenueN/A

CashN/A

DebtN/A

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK

Sector Finance and Insurance

Sub Sector Securities, Commodity Contracts, and Other Financial Investments and Related Activities

Market cap N/A

Competitor comparison

Ticker	Company	Price	Change
STT	State Street Corporation	$174.59	-1.79%
ETHE	Grayscale Ethereum Staking ETF Shares	$21.43	-0.83%
DHT.UN.CAT	DRI HEALTHCARE TRUST UNIT	$18.31	-0.60%
PPLT	abrdn Physical Platinum Shares ETF	$15.41	-0.39%
FXE	Invesco CurrencyShares Euro Currency Trust	$104.55	-0.11%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.